CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 366 filers reported holding CYTOKINETICS INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $715,935 | +309.1% | 13,214 | +429.4% | 0.01% | +200.0% |
Q1 2024 | $174,995 | -84.3% | 2,496 | -81.3% | 0.00% | -71.4% |
Q4 2023 | $1,115,426 | +455.8% | 13,360 | +96.1% | 0.01% | +133.3% |
Q3 2023 | $200,682 | +133.7% | 6,812 | +158.8% | 0.01% | +100.0% |
Q2 2023 | $85,856 | +67503.1% | 2,632 | -27.1% | 0.00% | -25.0% |
Q1 2023 | $127 | -78.1% | 3,611 | -71.5% | 0.00% | -83.3% |
Q4 2022 | $580 | -99.9% | 12,651 | -14.7% | 0.02% | +100.0% |
Q3 2022 | $718,000 | +24.9% | 14,827 | +1.3% | 0.01% | -7.7% |
Q2 2022 | $575,000 | +1497.2% | 14,635 | +1398.0% | 0.01% | – |
Q1 2022 | $36,000 | -89.0% | 977 | -86.4% | 0.00% | -100.0% |
Q4 2021 | $327,000 | +57.2% | 7,180 | +23.3% | 0.01% | +20.0% |
Q3 2021 | $208,000 | -33.8% | 5,822 | -63.4% | 0.01% | -37.5% |
Q2 2021 | $314,000 | +101.3% | 15,903 | +137.9% | 0.01% | +166.7% |
Q1 2021 | $156,000 | +437.9% | 6,686 | +383.4% | 0.00% | +200.0% |
Q4 2020 | $29,000 | -62.3% | 1,383 | -61.0% | 0.00% | 0.0% |
Q3 2020 | $77,000 | -57.2% | 3,547 | -53.6% | 0.00% | -85.7% |
Q2 2020 | $180,000 | +3500.0% | 7,652 | +1545.6% | 0.01% | – |
Q1 2020 | $5,000 | +25.0% | 465 | +17.7% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 395 | +182.1% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 140 | -79.0% | 0.00% | – |
Q4 2018 | $4,000 | -50.0% | 667 | -37.8% | 0.00% | -100.0% |
Q1 2018 | $8,000 | -80.5% | 1,073 | -78.7% | 0.00% | -80.0% |
Q4 2017 | $41,000 | +64.0% | 5,028 | +195.6% | 0.01% | +150.0% |
Q3 2017 | $25,000 | +66.7% | 1,701 | +38.4% | 0.00% | 0.0% |
Q2 2017 | $15,000 | +150.0% | 1,229 | +158.2% | 0.00% | +100.0% |
Q4 2016 | $6,000 | +200.0% | 476 | +113.5% | 0.00% | – |
Q3 2016 | $2,000 | -71.4% | 223 | -68.9% | 0.00% | -100.0% |
Q2 2016 | $7,000 | -22.2% | 716 | -44.1% | 0.00% | 0.0% |
Q1 2016 | $9,000 | +800.0% | 1,280 | +635.6% | 0.00% | – |
Q3 2015 | $1,000 | -96.7% | 174 | -96.1% | 0.00% | -100.0% |
Q1 2015 | $30,000 | – | 4,437 | +14690.0% | 0.00% | – |
Q3 2014 | $0 | -100.0% | 30 | -89.5% | 0.00% | – |
Q2 2014 | $1,000 | -50.0% | 286 | +43.0% | 0.00% | – |
Q1 2014 | $2,000 | +100.0% | 200 | +14.9% | 0.00% | – |
Q4 2013 | $1,000 | -94.1% | 174 | -92.4% | 0.00% | -100.0% |
Q3 2013 | $17,000 | – | 2,286 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |